Scholars@Duke
Journal cover image

APOL1 channel blocker reduces proteinuria in FSGS.

Publication ,  Journal Article
Olabisi, OA
Published in: Kidney Int
August 2023
Published version (DOI) Open Access Copy (Duke) Link to item

Duke Scholars

Opeyemi Olabisi
Author Opeyemi Olabisi Medicine, Nephrology

Published In

Kidney Int

DOI

10.1016/j.kint.2023.04.022

EISSN

1523-1755

Publication Date

August 2023

Volume

104

Issue

2

Start / End Page

228 / 230

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Proteinuria
  • Nephrotic Syndrome
  • Kidney
  • Humans
  • Glomerulosclerosis, Focal Segmental
  • Apolipoprotein L1
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Olabisi, O. A. (2023). APOL1 channel blocker reduces proteinuria in FSGS. Kidney Int, 104(2), 228–230. https://doi.org/10.1016/j.kint.2023.04.022
Olabisi, Opeyemi A. “APOL1 channel blocker reduces proteinuria in FSGS.” Kidney Int 104, no. 2 (August 2023): 228–30. https://doi.org/10.1016/j.kint.2023.04.022.
Olabisi OA. APOL1 channel blocker reduces proteinuria in FSGS. Kidney Int. 2023 Aug;104(2):228–30.
Olabisi, Opeyemi A. “APOL1 channel blocker reduces proteinuria in FSGS.” Kidney Int, vol. 104, no. 2, Aug. 2023, pp. 228–30. Pubmed, doi:10.1016/j.kint.2023.04.022.
Olabisi OA. APOL1 channel blocker reduces proteinuria in FSGS. Kidney Int. 2023 Aug;104(2):228–230.
Journal cover image

Published In

Kidney Int

DOI

10.1016/j.kint.2023.04.022

EISSN

1523-1755

Publication Date

August 2023

Volume

104

Issue

2

Start / End Page

228 / 230

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Proteinuria
  • Nephrotic Syndrome
  • Kidney
  • Humans
  • Glomerulosclerosis, Focal Segmental
  • Apolipoprotein L1
  • 3202 Clinical sciences
  • 1103 Clinical Sciences